Demographic differences among patients treated with chimeric antigen receptor T‐cell therapy in the United States

por Emole, Josephine, Lawal, Odunayo, Lupak, Oleksandra, Dias, Ajoy, Shune, Leyla, Yusuf, Korede
Publicado 2022

1602. Clostridium difficile Infection as a Predictor of Acute Graft vs. Host Disease Among Allogenic Stem Cell Transplant Recipients

por Jabr, Ra’Ed, Shune, Leyla, Atrouni, Wissam El, Telfah, Mohammad, Gao, Guangyi, He, Jianghua, Clough, Lisa
Publicado 2018

Hospitalization at the end of life in patients with multiple myeloma

por Abbasi, Saqib, Roller, John, Abdallah, Al-Ola, Shune, Leyla, McClune, Brian, Sborov, Douglas, Mohyuddin, Ghulam Rehman
Publicado 2021

De Novo Acute Myeloid Leukemia with Combined CBFB-MYH11 and BCR-ABL1 Gene Rearrangements: A Case Report and Review of Literature

por Sethapati, Venkata Rakesh, Jabr, Ra'ed, Shune, Leyla, El Atrouni, Wissam, Gonzales, Patrick R., Cui, Wei, Golem, Shivani
Publicado 2020

Adverse Hematological and Non-Hematological Events in Patients With Relapsed/Refractory Multiple Myeloma That Are Responsive to Daratumumab, Pomalidomide and Dexamethasone

por Alkharabsheh, Omar, Bellman, Polina, Mahmoudjafari, Zahra, Cui, Wei, Atrash, Shebli, Paul, Barry, Hashmi, Hamza, Shune, Leyla, Ahmed, Nausheen, Abdallah, Al-Ola
Publicado 2023

Outcomes of VDPACE with an immunomodulatory agent as a salvage therapy in relapsed/refractory multiple myeloma with extramedullary disease

por Abdallah, Al‐Ola, Mohyuddin, Ghulam Rehman, Ahmed, Nausheen, Mohan, Meera, Cui, Wei, Shune, Leyla, Mahmoudjafari, Zahra, McGuirk, Joseph, Ganguly, Siddhartha, Atrash, Shebli
Publicado 2021

Trends in Inpatient Chemotherapy Hospitalizations, Cost and Mortality for Patients with Acute Leukemias and Myeloma

por Gil, Kellen, Abbasi, Saqib, Mehta, Kathan, McClune, Brian, Sborov, Douglas, Ahmed, Nausheen, Abdallah, Al-Ola, Ganguly, Siddhartha, McGuirk, Joseph, Shune, Leyla, Mohyuddin, Ghulam Rehman
Publicado 2022

Non-secretory multiple myeloma with unusual TFG-ALK fusion showed dramatic response to ALK inhibition

por Masood, Ashiq, Christ, Trevor, Asif, Samia, Rajakumar, Priya, Gustafson, Beth A., Shune, Leyla O., Salahudeen, Ameen, Nedvad, Drew, Nanua, Suparna, Paner, Agne, Kuzel, Timothy M., Levy, Mia, Subramanian, Janakiraman, Raza, Shahzad
Publicado 2021

Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019

por Balmaceda, Nicole, Aziz, Muhammad, Chandrasekar, Viveksandeep Thoguluva, McClune, Brian, Kambhampati, Suman, Shune, Leyla, Abdallah, Al-Ola, Anwer, Faiz, Majeed, Aneela, Qazilbash, Muzaffar, Ganguly, Siddhartha, McGuirk, Joseph, Mohyuddin, Ghulam Rehman
Publicado 2021

“Waitlist mortality” is high for myeloma patients with limited access to BCMA therapy

por Ahmed, Nausheen, Wesson, William, Mushtaq, Muhammad Umair, Bansal, Rajat, AbdelHakim, Haitham, Bromert, Sarah, Appenfeller, Allison, Ghazal, Batool Abu, Singh, Anurag, Abhyankar, Sunil, Ganguly, Siddhartha, McGuirk, Joseph, Abdallah, Al-Ola, Shune, Leyla
Publicado 2023

Lessons Learned from COVID-19 Pandemic: Outcomes after Sars-Cov-2 Infection in Hematopoietic Cell Transplant and Cell Therapy Recipients

por Mushtaq, Muhammad Umair, Al-Ramahi, Joe S, Li, Kevin S, Shahzad, Moazzam, Chaudhary, Sibgha Gull, Balusu, Ramesh, Ahmed, Nausheen, Bansal, Rajat, Abdelhakim, Haitham, Shune, Leyla O., Singh, Anurag K., Abhyankar, Sunil H, McGuirk, Joseph P.
Publicado 2022

Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients

por Mushtaq, Muhammad Umair, Shahzad, Moazzam, Chaudhary, Sibgha Gull, Luder, Mary, Ahmed, Nausheen, Abdelhakim, Haitham, Bansal, Rajat, Balusu, Ramesh, DeJarnette, Shaun, Divine, Clint, Kribs, Robert, Shune, Leyla, Singh, Anurag K., Ganguly, Siddhartha, Abhyankar, Sunil H., McGuirk, Joseph P.
Publicado 2021

Lessons Learned from COVID-19 Pandemic: Outcomes after Sars-Cov-2 Infection in Hematopoietic Cell Transplant and Cell Therapy Recipients

por Mushtaq, Muhammad Umair, Al-Ramahi, Joe S, Li, Kevin, Shahzad, Moazzam, Chaudhary, Sibgha Gull, Nguyen, Andrea, DeJarnette, Shaun, Lutfi, Forat, Balusu, Ramesh, Ahmed, Nausheen, Bansal, Rajat, Abdelhakim, Haitham, Shune, Leyla, Singh, Anurag K., Abhyankar, Sunil H., McGuirk, Joseph P.
Publicado 2023

Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study

por Haverkos, Bradley, Alpdogan, Onder, Baiocchi, Robert, Brammer, Jonathan E., Feldman, Tatyana A., Capra, Marcelo, Brem, Elizabeth A., Nair, Santosh, Scheinberg, Phillip, Pereira, Juliana, Shune, Leyla, Joffe, Erel, Young, Patricia, Spruill, Susan, Katkov, Afton, McRae, Robert, Royston, Ivor, Faller, Douglas V., Rojkjaer, Lisa, Porcu, Pierluigi
Publicado 2023

Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN

por Nooka, Ajay K., Kaufman, Jonathan L., Rodriguez, Cesar, Jakubowiak, Andrzej, Efebera, Yvonne, Reeves, Brandi, Wildes, Tanya, Holstein, Sarah A., Anderson, Larry D., Badros, Ashraf, Shune, Leyla, Chari, Ajai, Pei, Huiling, Cortoos, Annelore, Patel, Sharmila, Bartlett, J. Blake, Vermeulen, Jessica, Lin, Thomas S., Richardson, Paul G., Voorhees, Peter
Publicado 2022

A Phase I/II Study of Twice Weekly Ixazomib Plus Pomalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma: Results from Phase I Dose Escalation Cohorts

por Nadeem, Omar, Mo, Clifton C, Laubach, Jacob P., Bianchi, Giada, Redd, Robert, Barth, Peter, Bayliss, Trevor J., Sanchorawala, Vaishali, Shune, Leyla, Distaso, Alexandra, Dalton, Virginia, Sperling, Adam S, Amweg, Laura, McKenney, Mary, Colson, Kathleen, Millard, Ella L, Hou, Isabella, Savell, Alexandra, Masone, Kelly, Munshi, Nikhil C., Ghobrial, Irene M., Anderson, Kenneth, Richardson, Paul G.
Publicado 2020

A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-cell Stemness Shows Enhanced CAR T-cell Efficacy in Preclinical and Early Clinical Development

por Dickinson, Michael J., Barba, Pere, Jäger, Ulrich, Shah, Nirav N., Blaise, Didier, Briones, Javier, Shune, Leyla, Boissel, Nicolas, Bondanza, Attilio, Mariconti, Luisa, Marchal, Anne-Laure, Quinn, David S., Yang, Jennifer, Price, Andrew, Sohoni, Akash, Treanor, Louise M., Orlando, Elena J., Mataraza, Jennifer, Davis, Jaclyn, Lu, Darlene, Zhu, Xu, Engels, Boris, Moutouh-de Parseval, Laure, Brogdon, Jennifer L., Moschetta, Michele, Flinn, Ian W.
Publicado 2023

Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy

por Ferreri, Christopher J., Hildebrandt, Michelle A. T., Hashmi, Hamza, Shune, Leyla O., McGuirk, Joseph P., Sborov, Douglas W., Wagner, Charlotte B., Kocoglu, M. Hakan, Rapoport, Aaron, Atrash, Shebli, Voorhees, Peter M., Khouri, Jack, Dima, Danai, Afrough, Aimaz, Kaur, Gurbakhash, Anderson, Larry D., Simmons, Gary, Davis, James A., Kalariya, Nilesh, Peres, Lauren C., Lin, Yi, Janakiram, Murali, Nadeem, Omar, Alsina, Melissa, Locke, Frederick L., Sidana, Surbhi, Hansen, Doris K., Patel, Krina K., Castaneda Puglianini, Omar Alexis
Publicado 2023